Trimethylamine N‐Oxide ( TMAO ) and TNF ‐α Levels in Periodontal Disease Associated With Smoking
Oral Diseases · 2025-07 · 31 (7) · 2282-2292
DOI: 10.1111/odi.15262 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Oral Diseases, online erschienen am 30.01.2025. Verfasst von Ipek Bal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Institute of Health Sciences, Istanbul Medipol University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Methylamines, Periodontitis, Saliva, Smoking. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Aims
Trimethylamine N‐oxide (TMAO) is a compound involved in the pathogenesis of various systemic inflammatory diseases, including cardiovascular conditions. The aim of this study was to determine differences in saliva and serum levels of TMAO between periodontitis and healthy patients according to smoking status.
Methods
The study included four systemically healthy groups: periodontally healthy non‐smokers (NS‐Control; n = 25), non‐smokers with Stage‐III‐Grade‐B periodontitis (NS‐Periodontitis; n = 25), periodontally healthy smokers (S‐Control; n = 25), and smokers with Stage‐III Grade‐C periodontitis (S‐Periodontitis; n = 25). Periodontal parameters were recorded. TMAO levels were determined in saliva and serum samples using liquid chromatography‐mass spectrometry (LC–MS/MS). TNF‐α levels were measured by the ELISA method.
Results
Salivary TNF‐α and TMAO levels were significantly elevated in the smoking periodontitis group compared to other groups ( p < 0.001 and p = 0.003, respectively). Serum TMAO levels were also significantly higher in the smoking periodontitis group compared to non‐smoking controls and non‐smoking periodontitis. TMAO/SFR ratios were notably higher in the smoking periodontitis group compared to other groups, and a strong positive correlation was observed between salivary TMAO and TNF‐α levels ( r = 0.892, p < 0.001).
Conclusion
The data suggested that TMAO and TNF‐α are associated with inflammatory mechanisms of periodontitis in cases where periodontitis coexists with smoking. Trial Registration NCT06580431
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Institute of Health Sciences, Istanbul Medipol University, Istanbul, Turkey.
- Department of Periodontology, Faculty of Dentistry, Istanbul Medipol University, Istanbul, Turkey.
- Department of Medical Biology and Genetics, School of Medicine, Ankara Medipol University, Ankara, Turkey.
- Department of Periodontology, Faculty of Dentistry, Ankara University, Ankara, Turkey.
- Department of Medical Biochemistry, School of Medicine, Acibadem University, Istanbul, Turkey.
ORCID-Profile: Nur Balci
Zitieren
APA
Bal, I., Balci, N., Sorguc, C., Toygar, H. U., Serdar, C. C., Kurgan, S., & Serdar, M. A. (2025). Trimethylamine N‐Oxide ( TMAO ) and TNF ‐α Levels in Periodontal Disease Associated With Smoking. Oral Diseases, 31(7), 2282-2292. https://doi.org/10.1111/odi.15262
Vancouver
Bal I, Balci N, Sorguc C, Toygar HU, Serdar CC, Kurgan S, et al. Trimethylamine N‐Oxide ( TMAO ) and TNF ‐α Levels in Periodontal Disease Associated With Smoking. Oral Diseases. 2025;31(7):2282-2292. doi:10.1111/odi.15262
BibTeX
@article{Bal2025,
author = {Bal, Ipek and Balci, Nur and Sorguc, Cem and Toygar, Hilal Uslu and Serdar, Ceyhan C and Kurgan, Sivge and Serdar, Muhittin A},
title = {Trimethylamine N‐Oxide ( TMAO ) and TNF ‐α Levels in Periodontal Disease Associated With Smoking},
journal = {Oral Diseases},
year = {2025},
volume = {31},
number = {7},
pages = {2282--2292},
doi = {10.1111/odi.15262}
}
EUVIMED